A citation-based method for searching scientific literature

Christophe Massard, Stefan Michiels, Charles Ferté, Marie-Cécile Le Deley, Ludovic Lacroix, Antoine Hollebecque, Loic Verlingue, Ecaterina Ileana, Silvia Rosellini, Samy Ammari, Maud Ngo-Camus, Rastislav Bahleda, Anas Gazzah, Andrea Varga, Sophie Postel-Vinay, Yohann Loriot, Caroline Even, Ingrid Breuskin, Nathalie Auger, Bastien Job, Thierry De Baere, Frederic Deschamps, Philippe Vielh, Jean-Yves Scoazec, Vladimir Lazar, Catherine Richon, Vincent Ribrag, Eric Deutsch, Eric Angevin, Gilles Vassal, Alexander Eggermont, Fabrice André, Jean-Charles Soria. Cancer Discov 2017
Times Cited: 368



Loic Verlingue, David Malka, Adrien Allorant, Christophe Massard, Charles Ferté, Ludovic Lacroix, Etienne Rouleau, Nathalie Auger, Maud Ngo, Claudio Nicotra, Thierry De Baere, Lambros Tselikas, Bakar Ba, Stefan Michiels, Jean-Yves Scoazec, Valérie Boige, Michel Ducreux, Jean-Charles Soria, Antoine Hollebecque. Eur J Cancer 2017
Times Cited: 74




List of shared articles



Times cited

Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review).
Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Lorenz Thurner, Manfred Ahlgrimm, Stephan Stilgenbauer, Moritz Bewarder, Dominic Kaddu-Mulindwa. Mol Clin Oncol 2022
3

ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma.
Helena Verdaguer, Tamara Saurí, Daniel Alejandro Acosta, Magdalena Guardiola, Alexandre Sierra, Jorge Hernando, Paulo Nuciforo, Josep M Miquel, Cristina Molero, Sandra Peiró,[...]. Clin Cancer Res 2022
3

Advances in the systemic treatment of therapeutic approaches in biliary tract cancer.
O Mirallas, D López-Valbuena, D García-Illescas, C Fabregat-Franco, H Verdaguer, J Tabernero, T Macarulla. ESMO Open 2022
0

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.
Kathrin Heinrich, Lisa Miller-Phillips, Frank Ziemann, Korbinian Hasselmann, Katharina Rühlmann, Madeleine Flach, Dorottya Biro, Michael von Bergwelt-Baildon, Julian Holch, Tobias Herold,[...]. J Cancer Res Clin Oncol 2022
1

Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, Roberta Elisa Rossi, Raffaella Longarini, Anna Maria Stagno, Laura Cristoferi, Antonio Ciaccio, Diego Luigi Cortinovis, Pietro Invernizzi,[...]. Ann Hepatol 2022
1

Molecular therapeutic targets for cholangiocarcinoma: Present challenges and future possibilities.
Dan Høgdall, Colm J O'Rourke, Jesper B Andersen. Adv Cancer Res 2022
1


Molecular Targets in Cholangiocarcinoma.
Colm J O'Rourke, Patricia Munoz-Garrido, Jesper B Andersen. Hepatology 2021
20

Will advanced cholangiocarcinoma become a targetable malignancy?
Yara Sarkis, Amine Al Soueidy, Hampig Raphael Kourie. Crit Rev Oncol Hematol 2021
1

Rare cancer, rare alteration: the case of NTRK fusions in biliary tract cancers.
Alice Boilève, Loïc Verlingue, Antoine Hollebecque, Valérie Boige, Michel Ducreux, David Malka. Expert Opin Investig Drugs 2021
5